Understanding the big hitters in Lou Gehrig’s disease: loading our knowledge bases to discover a home run for treatment

Written by Ryan Gilroy (Commissioning Editor)

In recent weeks several research papers have been published all providing valuable new insight into the roles and functions of key proteins and pathways involved in amyotrophic lateral sclerosis (ALS).   Three strikes for ALS ALS, commonly referred to as Lou Gehrig’s disease after the former baseball pro who is thought to have suffered from the condition, is a common and fatal neuromuscular disorder that currently has no cure. Approximately 10% of ALS cases are caused by inherited genetic factors; however, whilst many risk factors correlated with ALS onset have been observed, the remaining percentage of cases do not have a clearly defined cause.   Current treatments and diagnostics for ALS are limited by our underlying knowledge of the disease and a lack of identified ALS biomarkers and therapeutic targets. To improve...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!